Significant variation in application of active surveillance

According to an article in the journal Cancer, men with low-risk prostate cancer diagnosed and managed at high-volume hospitals are 3.6 times more likely to be managed on active surveillance than those managed at low-volume institutions. … READ MORE …

Immunotherapy for the treatment of prostate cancer

The Society for Immunotherapy of Cancer has just issued a detailed statement on the role of immunotherapy in the management of prostate cancer. The full text of this article by McNeel et al. is available on line. … READ MORE …

An unfortunately misleading statement in the AFP

Back in 2014, the American Cancer Society (ACS) issued a really rather thorough set of guidelines on the long-term management of survivors after initial treatment for prostate cancer. … READ MORE …

NCCN expands role for active surveillance in initial management of localized prostate cancer

In its most recent update to its guidelines on the management of prostate cancer, the National Comprehensive Cancer Network (NCCN) has now stated that active surveillance is a first-line option for the management of favorable, intermediate-risk prostate cancer. … READ MORE …

NCCN issues revised prostate cancer management guidelines for 2016

The National Comprehensive Cancer Consortium (NCCN) has just released its updated 2016 guidelines on the management of prostate cancer for physicians. … READ MORE …

From the past to the future … the appropriate use of active monitoring

A new article just published in the journal Cancer concludes that “active surveillance is underused” in the management of low-risk prostate cancer. However, one has to be careful about how one interpret the data in (and the conclusions of) this particular article. … READ MORE …

Selection of appropriate candidates for management with active surveillance

In this month’s issue of the Journal of Urology, Dr. Peter Carroll (of UCSF) and Dr. Mark Dall’Era (formerly of UCSF and now at UCDavis) have contributed an editorial entitled “What is the optimal way to select candidates for active surveillance of prostate cancer?” … READ MORE …

ASCO endorses ACS’s prostate cancer survivorship guidelines

In June last year the American Cancer Society (ACS) published the first-ever set of long-term care guidelines for prostate cancer survivors. The “New” Prostate Cancer InfoLink addressed and discussed those guidelines at the time of their publication. … READ MORE …

New draft Australian guidelines (on screening and expectant management)

A group of Australian experts has just released new draft guidance on prostate cancer screening and the role of expectant management (active surveillance and/or watchful waiting) in the management of prostate cancer. … READ MORE …

Nutritional guidance for cancer patients

According to a new article in the journal Nutrition and Cancer, “Consistent online dietary recommendations are lacking for patients during and after cancer treatment.” This will hardly come as a shock to many in the prostate cancer community, but an article like this one may help to initiate development of better guidelines. … READ MORE …

NCCN issues cancer “survivorship” guidelines for clinicians

According to a report on the Medscape Oncology web site this morning, the National Comprehensive Cancer Network (NCCN) has just released, for the first time, guidelines for clinicians that address factors affecting “survivorship” after a diagnosis of and treatment for cancer. … READ MORE …

Differing perspectives on prostate cancer testing for healthy men

As fodder for the ongoing discussion about the appropriateness of PSA testing (particularly of younger, healthy men) and risk for prostate cancer, we would draw our reader’s attention to an article from the Annals of Family Medicine just reprinted on the Medscape web site. … READ MORE …

ASCO says most “hi tech” scans are inappropriate in low-risk prostate cancer

In an article just published in the Journal of Clinical Oncology, the American Society of Clinical Oncology (ASCO) has strongly recommended against the use of advanced imaging technologies  for determining the spread of prostate cancer in men with early stage, low-risk disease. … READ MORE …

ACS rolls out new process for developing cancer guidelines

Many organizations develop guidelines for the prevention, diagnosis, and treatment of cancer (prostate cancer included). And the differences between these guidelines can be striking and controversial … READ MORE …

Beyond the Abstract — Treatment options for localized prostate cancer

The following article, by Ravinder Mohan, MD, PhD, is reproduced from the UroToday web site with kind permission of Dr. Mohan and the publishers of UroToday. We had previously commented on the original article, published last month in American Family Physician. … READ MORE …